Advantage Alpha Capital Partners LP Invests $4.11 Million in Mirion Technologies, Inc. (NYSE:MIR)

Advantage Alpha Capital Partners LP bought a new stake in shares of Mirion Technologies, Inc. (NYSE:MIR) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 235,565 shares of the company’s stock, valued at approximately $4,111,000. Advantage Alpha Capital Partners LP owned 0.10% of Mirion Technologies at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Swiss National Bank grew its position in shares of Mirion Technologies by 0.5% during the 4th quarter. Swiss National Bank now owns 376,800 shares of the company’s stock valued at $6,575,000 after acquiring an additional 2,000 shares during the period. Xponance Inc. grew its holdings in Mirion Technologies by 15.9% during the fourth quarter. Xponance Inc. now owns 14,942 shares of the company’s stock valued at $261,000 after purchasing an additional 2,048 shares during the period. KBC Group NV increased its position in Mirion Technologies by 39.2% in the fourth quarter. KBC Group NV now owns 8,002 shares of the company’s stock worth $140,000 after buying an additional 2,254 shares in the last quarter. Handelsbanken Fonder AB lifted its position in shares of Mirion Technologies by 10.5% during the 4th quarter. Handelsbanken Fonder AB now owns 61,031 shares of the company’s stock valued at $1,065,000 after buying an additional 5,800 shares in the last quarter. Finally, Quest Partners LLC grew its stake in shares of Mirion Technologies by 680.5% during the 3rd quarter. Quest Partners LLC now owns 6,728 shares of the company’s stock valued at $74,000 after acquiring an additional 5,866 shares during the period. 78.51% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. The Goldman Sachs Group raised their target price on shares of Mirion Technologies from $16.00 to $21.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Robert W. Baird started coverage on shares of Mirion Technologies in a research note on Thursday, December 19th. They set an “outperform” rating and a $22.00 target price on the stock. Baird R W upgraded Mirion Technologies to a “strong-buy” rating in a research note on Thursday, December 19th. Finally, Citigroup boosted their price objective on Mirion Technologies from $18.00 to $20.00 and gave the company a “buy” rating in a research report on Wednesday, December 4th. Three analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $19.25.

Mirion Technologies Stock Performance

Shares of NYSE MIR opened at $15.22 on Monday. The firm’s fifty day moving average is $15.69 and its two-hundred day moving average is $15.00. Mirion Technologies, Inc. has a 52-week low of $9.11 and a 52-week high of $18.81. The company has a market cap of $3.54 billion, a P/E ratio of -80.10 and a beta of 0.74. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.55 and a current ratio of 2.16.

Mirion Technologies (NYSE:MIR) last posted its earnings results on Tuesday, February 11th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.14 by $0.02. Mirion Technologies had a positive return on equity of 4.78% and a negative net margin of 4.21%. As a group, analysts anticipate that Mirion Technologies, Inc. will post 0.39 EPS for the current fiscal year.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.